BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16094510)

  • 1. Drug targeting with nano-sized carrier systems.
    Yokoyama M
    J Artif Organs; 2005; 8(2):77-84. PubMed ID: 16094510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug delivery systems using nano-sized drug carriers].
    Nakayama M; Okano T
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):935-40. PubMed ID: 16044950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-inspired chimeric drug delivery nano systems (Chi-DDnSs): their fractal hologram and regulatory aspects.
    Pippa N; Pispas S; Demetzos C
    Adv Exp Med Biol; 2015; 822():199-200. PubMed ID: 25416991
    [No Abstract]   [Full Text] [Related]  

  • 4. The fractal analysis as a complementary approach to predict the stability of drug delivery nano systems (DDnSs) in aqueous and biological media: a regulatory proposal or a dream?
    Demetzos C; Pippa N
    Adv Exp Med Biol; 2015; 822():211-2. PubMed ID: 25416995
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanotechnology Inspired Advanced Engineering Fundamentals for Optimizing Drug Delivery.
    Kassem AA
    Curr Drug Targets; 2018; 19(15):1839-1854. PubMed ID: 29412103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional DNA Origami Nanoplatforms for Drug Delivery.
    Lu X; Liu J; Wu X; Ding B
    Chem Asian J; 2019 Jul; 14(13):2193-2202. PubMed ID: 31125182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured formulations and drug delivery systems.
    Bunt CR
    Pharm Dev Technol; 2018 Apr; 23(4):315. PubMed ID: 29514576
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioinspired Platform Conjugated Active Drug Delivery.
    Shao J; Xuan M; He Q; Dai L
    Curr Drug Targets; 2018 Feb; 19(4):328-338. PubMed ID: 27262485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeting of anti-cancer drugs with nano-sized carrier system].
    Yokoyama M; Okano T
    Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced drug delivery nanosystems: perspectives and regulatory issues.
    Demetzos C
    Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.
    D'Souza GG; Weissig V
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1135-48. PubMed ID: 19708822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nanotechnology applications in pharmacology].
    Seĭfulla RD; Timofeev AB; Ordzhonikidze ZG; Rozhkova EA; Kulikova EV; Druzhinin AE; Kuznetsov IuM; Kim EK
    Eksp Klin Farmakol; 2008; 71(1):61-9. PubMed ID: 18365491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery.
    Robitzki AA; Kurz R
    Handb Exp Pharmacol; 2010; (197):87-112. PubMed ID: 20217527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
    Kumar A; Pandey AN; Jain SK
    Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
    Cevc G; Vierl U
    J Control Release; 2010 Feb; 141(3):277-99. PubMed ID: 19850095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
    Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
    Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
    Ahmed RZ; Patil G; Zaheer Z
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.